Bruce Goldsmith is the founder of Passage Bio. Passage Bio has raised $225M in total funding. Based in Philadelphia, PA.
Bruce Goldsmith, Ph.D., was appointed Chief Executive Officer of Passage Bio, a biotechnology company focused on developing gene therapies for rare neurological diseases. He has led the company through pre-clinical data presentations and strategic updates.
Full founder directory · Investor directory · Company funding database · Fundraising library